| Mohammed A Allaw, MD | |
|
4015 Gateway Blvd, Newburgh, IN 47630-8925 | |
| (812) 858-6244 | |
| (812) 858-6240 |
| Full Name | Mohammed A Allaw |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 35 Years |
| Location | 4015 Gateway Blvd, Newburgh, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336142728 | NPI | - | NPPES |
| 200127980 | Medicaid | IN | |
| 000000042183 | Other | IN | BCBS PIN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 01045554A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Deaconess Home Health, Llc | Evansville, IN | Home health agency |
| Deaconess Hospital Inc | Evansville, IN | Hospital |
| Women's Hospital The | Newburgh, IN | Hospital |
| Methodist Hospital | Henderson, KY | Hospital |
| Gibson General Hospital | Princeton, IN | Hospital |
| Owensboro Health Regional Hospital | Owensboro, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Deaconess Clinic Inc | 3375610116 | 337 |
| Deaconess Hospital Inc | 9032021431 | 308 |
| Legacy Healthcare Services Inc | 2163339722 | 2654 |
News Archive
Aton Pharma, Inc., a diversified specialty pharmaceutical company, today announced it has acquired the U.S. marketing rights to the Timoptic product line from Merck & Co., Inc. Timoptic (timolol maleate) is a non-selective beta-adrenergic receptor blocking agent indicated for the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.
Kewaunee Scientific Corporation today reported results for its first quarter ended July 31, 2015.
Common practice in the treatment of adolescent eating disorder patients has been to exclude the parents. Many experts consider parents part of the problem and thus keep them away during therapy.
Scientists have shown new genetic evidence that could strengthen the link between the role of dietary fats with colon cancer progression.
The purported "game-changer" anti-malarial drug Hydroxychloroquine, which was claimed to be effective in preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and also helping better outcomes in COVID-19 patients, seems to have failed in clinical trials.
› Verified 3 days ago
| Entity Name | Deaconess Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427097443 PECOS PAC ID: 9032021431 Enrollment ID: O20040115000129 |
News Archive
Aton Pharma, Inc., a diversified specialty pharmaceutical company, today announced it has acquired the U.S. marketing rights to the Timoptic product line from Merck & Co., Inc. Timoptic (timolol maleate) is a non-selective beta-adrenergic receptor blocking agent indicated for the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.
Kewaunee Scientific Corporation today reported results for its first quarter ended July 31, 2015.
Common practice in the treatment of adolescent eating disorder patients has been to exclude the parents. Many experts consider parents part of the problem and thus keep them away during therapy.
Scientists have shown new genetic evidence that could strengthen the link between the role of dietary fats with colon cancer progression.
The purported "game-changer" anti-malarial drug Hydroxychloroquine, which was claimed to be effective in preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and also helping better outcomes in COVID-19 patients, seems to have failed in clinical trials.
› Verified 3 days ago
| Entity Name | Deaconess Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619123585 PECOS PAC ID: 3375610116 Enrollment ID: O20080922000145 |
News Archive
Aton Pharma, Inc., a diversified specialty pharmaceutical company, today announced it has acquired the U.S. marketing rights to the Timoptic product line from Merck & Co., Inc. Timoptic (timolol maleate) is a non-selective beta-adrenergic receptor blocking agent indicated for the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.
Kewaunee Scientific Corporation today reported results for its first quarter ended July 31, 2015.
Common practice in the treatment of adolescent eating disorder patients has been to exclude the parents. Many experts consider parents part of the problem and thus keep them away during therapy.
Scientists have shown new genetic evidence that could strengthen the link between the role of dietary fats with colon cancer progression.
The purported "game-changer" anti-malarial drug Hydroxychloroquine, which was claimed to be effective in preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and also helping better outcomes in COVID-19 patients, seems to have failed in clinical trials.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mohammed A Allaw, MD Po Box 1510, Evansville, IN 47706-1510 Ph: (812) 858-6244 | Mohammed A Allaw, MD 4015 Gateway Blvd, Newburgh, IN 47630-8925 Ph: (812) 858-6244 |
News Archive
Aton Pharma, Inc., a diversified specialty pharmaceutical company, today announced it has acquired the U.S. marketing rights to the Timoptic product line from Merck & Co., Inc. Timoptic (timolol maleate) is a non-selective beta-adrenergic receptor blocking agent indicated for the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.
Kewaunee Scientific Corporation today reported results for its first quarter ended July 31, 2015.
Common practice in the treatment of adolescent eating disorder patients has been to exclude the parents. Many experts consider parents part of the problem and thus keep them away during therapy.
Scientists have shown new genetic evidence that could strengthen the link between the role of dietary fats with colon cancer progression.
The purported "game-changer" anti-malarial drug Hydroxychloroquine, which was claimed to be effective in preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and also helping better outcomes in COVID-19 patients, seems to have failed in clinical trials.
› Verified 3 days ago
Dr. Robert Ernest Swaney Iii, MD, MSPH, FACP Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3699 Epworth Rd, Newburgh, IN 47630 Phone: 812-471-1200 | |
Dr. Maruthi Srikanth Penumetsa, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4007 Gateway Blvd # 100, Newburgh, IN 47630 Phone: 812-842-0907 Fax: 812-490-7919 | |
Dr. Frank X Pamelia, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 4007 Gateway Blvd, Ste100, Newburgh, IN 47630 Phone: 812-842-0907 Fax: 812-490-5536 | |
Dr. Prasanna Lakshmi Yelamanchili, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4007 Gateway Blvd, Ste 100, Newburgh, IN 47630 Phone: 812-842-0907 Fax: 812-490-7054 | |
Dr. Leslie Rae Pike Brown, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3699 Epworth Rd, Newburgh, IN 47630 Phone: 812-471-1200 | |
Mr. Mohammad Bashar Mourad, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 9355 Warrick Trl, Newburgh, IN 47630 Phone: 270-689-1919 Fax: 270-689-1990 | |
Mr. Ashwin Sabarivijay Durairaj, M.D Internal Medicine Medicare: Medicare Enrolled Practice Location: 4007 Gateway Blvd, Newburgh, IN 47630 Phone: 812-464-9133 Fax: 812-464-0559 |